Extend your brand profile by curating daily news.

Earth Science Tech Uplists to OTCQB Venture Market, Marking Fiscal 2027 Milestones

By Advos•
Earth Science Tech's uplisting to the OTCQB Venture Market provides investors with a trusted trading environment and follows a series of fiscal 2027 milestones including revenue growth, acquisitions, and an annual shareholder meeting.
Earth Science Tech Uplists to OTCQB Venture Market, Marking Fiscal 2027 Milestones

Earth Science Tech (OTCQB: ETST), a strategic holding company in the healthcare, pharmacy, and telemedicine sector, successfully uplisted to the OTCQB Venture Market effective September 17, 2026. The listing on OTCQB, an established public market for growth-stage and entrepreneurial companies, means ETST has met rigorous financial and reporting standards, undergone a verification process, and complied with strict management certification requirements (https://ibn.fm/0TQ91).

The uplisting is the latest milestone in fiscal year 2027, which began on April 1, 2026. During the intervening period, the company reported its Q1 2027 financial results, acquired Meduvo LLC (a compounding pharmacy) and Zoolzy LLC, and held its annual meeting of shareholders. These developments underscore Earth Science Tech's strategic expansion and operational progress.

For investors, the OTCQB Venture Market offers a trusted trading environment with enhanced transparency and liquidity compared to lower-tier markets. The uplisting could attract a broader investor base and improve the company's visibility within the investment community. As a holding company in the healthcare, pharmacy, and telemedicine sector, Earth Science Tech's move to OTCQB may also signal growth potential in these industries, which are increasingly driven by technological innovation and changing consumer demands.

The company's Q1 2027 financial results showed a 3% growth in revenue and a 57% increase in net income, indicating improved profitability. The acquisitions of Meduvo LLC and Zoolzy LLC are expected to complement Earth Science Tech's existing operations and expand its service offerings. Meduvo LLC, a compounding pharmacy, adds capabilities in personalized medication, while Zoolzy LLC may bring additional synergies. The annual meeting of shareholders provided an opportunity for the company to engage with its investors and outline its strategic direction.

InvestorWire (InvestorWire), a specialized communications platform, has been covering Earth Science Tech's progress. As part of the Dynamic Brand Portfolio at IBN, InvestorWire provides wire-grade press release syndication and editorial syndication to 5,000+ outlets, ensuring that news like Earth Science Tech's uplisting reaches a wide audience. The platform also offers press release enhancement and social media distribution to maximize impact.

The uplisting to OTCQB is significant for Earth Science Tech as it validates the company's adherence to high financial and reporting standards. It may also enhance the company's credibility among institutional investors and analysts, potentially leading to increased trading volume and share price stability. For the broader healthcare and telemedicine sector, this move highlights the growing interest in companies that integrate pharmacy services with digital health solutions.

Investors and industry watchers will be keen to see how Earth Science Tech leverages its new market status to further its growth trajectory. The company's ability to execute on its acquisition strategy and deliver financial improvements will be critical in sustaining momentum. As fiscal 2027 progresses, Earth Science Tech's performance on the OTCQB will be a key indicator of its long-term potential.

For more information, please visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.

Advos

Advos

@advos